Corvus Pharmaceuticals has faced volatility due to mixed clinical data and given the current valuation and market ...

Corvus Pharmaceuticals suffered lately, especially after it announced in December 2024 its early AD data. Check out why I ...

Q4 2024 Earnings Call Transcript March 25, 2025 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

Thank you for standing by and welcome to the Corvus Pharmaceuticals fourth-quarter and full-year 2024 business update and financial results conference call. (Operator Instructions) It is now my ...

Insiders who purchased Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS ) shares in the past 12 months are unlikely to ...

Stock analysts at HC Wainwright lifted their FY2025 earnings per share estimates for shares of Corvus Pharmaceuticals in a ...

Corvus Pharmaceuticals stock opened at $3.35 on Wednesday. The stock has a market cap of $215.26 million, a PE ratio of -3.60 and a beta of 0.91. The business’s 50-day moving average price is $4 ...

Find out more about Buckhout, the newly appointed deputy assistant secretary of defense for cyber policy, a 26-year military veteran and a former congressional candidate.

On Thursday, 27 March 2025, Corvus Pharmaceuticals (NASDAQ: CRVS) presented at the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference. The company provided an update ...

The Defense Department has named former Army official Laurie Buckhout as its new cyber policy chief, according to an announcement today. Buckhout, an Army veteran who served as chief of the service’s ...